MKI67 and neoplasm: Boninsegna et al. have previously found that a Ki-67 of more than 5% is a predictor of recurrent disease (9). In a previous study of 24 patients, re-biopsies of tumor relapse displayed increased Ki-67 counts, from median 4% to 11%, of whom four (17%) progressed to G3 lesions (16).